Literature DB >> 21061094

Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism.

Dilek Berker1, Serhat Isik, Ufuk Ozuguz, Yasemin Ates Tutuncu, Kerim Kucukler, Gulhan Akbaba, Yusuf Aydin, Serdar Guler.   

Abstract

In patients, who undergo surgery for hyperthyroidism, many cases of incidental thyroid cancer (ITC) have been detected. In the literature, there is no study about ITC in subcentimeter nodules in these patients. We performed this study to determine the frequency of ITC in subcentimeter nodules and ultrasonographic features that can predict malignancy in the patients with hyperthyroidism. We retrospectively reviewed our database about 3114 patients, who underwent thyroidectomy in our hospital. Among 869 patients (27.9%), who were operated because of hyperthyroidism, we enrolled 337 patients, who underwent total thyroidectomy and had subcentimeter nodule [59 Graves’ disease (GD) 98 subcentimeter nodule; 278 toxic multinodular goitre (TMNG), 359 subcentimeter nodule], in this study. Twenty-five nodules with ITC and 432 benign nodules have been detected and compared for ultrasonographic (US) features. Incidental thyroid cancer detection ratio was 5.4% [10.2% (10/98) in subcentimeter thyroid nodules in individuals with GD, and 4.1% (15/359) in individuals with TMNG, P = 0.018)]. Significant differences have been observed between the groups in terms of microcalcification in US examination of malign and benign subcentimeter thyroid nodules and the ratio of anterioposterior diameter to transverse diameter (A/T) ≥1 [(OR = 5.172; 95% CI: 1.495–17.886, P = 0.015), and (OR = 5.930; 95% CI: 1.531–22.971, P = 0.007), respectively]. We detected a higher incidence of ITC in subcentimeter thyroid nodules in GD compared to TMNG. US examination of subcentimeter nodules in hyperthyroid individuals has indicated that microcalcification and ratio of A/T ≥1 are the parameters that predict malignancy.

Entities:  

Mesh:

Year:  2011        PMID: 21061094     DOI: 10.1007/s12020-010-9405-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  32 in total

1.  Thyroid nodule shape suggests malignancy.

Authors:  Carlo Cappelli; Maurizio Castellano; Ilenia Pirola; Elena Gandossi; Elvira De Martino; Davide Cumetti; Barbara Agosti; Enrico Agabiti Rosei
Journal:  Eur J Endocrinol       Date:  2006-07       Impact factor: 6.664

Review 2.  Papillary thyroid microcarcinoma: a surgical perspective.

Authors:  George H Sakorafas; John Giotakis; Vania Stafyla
Journal:  Cancer Treat Rev       Date:  2005-07-06       Impact factor: 12.111

3.  c-myc expression is associated with increased proliferation activity in thyroid follicular cells of Graves' disease as stimulated by autoantibodies.

Authors:  K Kashima; S Yokoyama; T Daa; K Takahashi; I Nakayama; S Noguchi
Journal:  Eur J Endocrinol       Date:  1996-07       Impact factor: 6.664

Review 4.  Environmental iodine intake affects the type of nonmalignant thyroid disease.

Authors:  P Laurberg; I Bülow Pedersen; N Knudsen; L Ovesen; S Andersen
Journal:  Thyroid       Date:  2001-05       Impact factor: 6.568

5.  Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.

Authors:  G Viglietto; A Romano; G Manzo; G Chiappetta; I Paoletti; D Califano; M G Galati; V Mauriello; P Bruni; C T Lago; A Fusco; M G Persico
Journal:  Oncogene       Date:  1997-11-27       Impact factor: 9.867

6.  The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey.

Authors:  F Aghini-Lombardi; L Antonangeli; E Martino; P Vitti; D Maccherini; F Leoli; T Rago; L Grasso; R Valeriano; A Balestrieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

7.  Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland.

Authors:  K O Franssila; H R Harach
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

8.  The value of fine-needle aspiration biopsy in subcentimeter thyroid nodules.

Authors:  Dilek Berker; Yusuf Aydin; Ihsan Ustun; Kamile Gul; Yasemin Tutuncu; Serhat Işik; Tuncay Delibasi; Serdar Guler
Journal:  Thyroid       Date:  2008-06       Impact factor: 6.568

9.  Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?

Authors:  Nimmi Arora; Harma K Turbendian; Meredith A Kato; Tracy A Moo; Rasa Zarnegar; Thomas J Fahey
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

10.  Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor.

Authors:  J Van Sande; C Lejeune; M Ludgate; D S Munro; G Vassart; J E Dumont; J Mockel
Journal:  Mol Cell Endocrinol       Date:  1992-10       Impact factor: 4.102

View more
  10 in total

1.  The comparison of accuracy of ultrasonographic features versus ultrasound-guided fine-needle aspiration cytology in diagnosis of malignant thyroid nodules.

Authors:  Mehrdad Nabahati; Zoleika Moazezi; Soude Fartookzadeh; Rahele Mehraeen; Naser Ghaemian; Majid Sharbatdaran
Journal:  J Ultrasound       Date:  2019-04-10

2.  The association of menstrual and reproductive factors with thyroid nodules in Chinese women older than 40 years of age.

Authors:  Kun Wang; Yu Yang; Yang Wu; Jie Chen; Danyu Zhang; Chao Liu
Journal:  Endocrine       Date:  2014-07-11       Impact factor: 3.633

3.  Predictive factors of thyroid cancer in patients with Graves' disease.

Authors:  Meng Ren; Mu Chao Wu; Chang Zhen Shang; Xiao Yi Wang; Jing Lu Zhang; Hua Cheng; Ming Tong Xu; Li Yan
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

4.  Incidentally discovered thyroid nodules: frequency in an adult population during Doppler ultrasonographic evaluation of cervical vessels.

Authors:  Turker Acar; Suha Sureyya Ozbek; Seval Acar
Journal:  Endocrine       Date:  2013-04-08       Impact factor: 3.633

5.  Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.

Authors:  Onajite Kousin-Ezewu; Alasdair Coles
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

Review 6.  Alemtuzumab therapy for multiple sclerosis.

Authors:  Alasdair J Coles
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

7.  The prevalence of thyroid cancer in patients with hyperthyroidism.

Authors:  Fathimabeebi P Kunjumohamed; Noor B Al-Busaidi; Hilal N Al-Musalhi; Sulaiman Z Al-Shereiqi; Issa S Al-Salmi
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

8.  Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis.

Authors:  Lorraine W Lau; Sana Ghaznavi; Alexandra D Frolkis; Alexandra Stephenson; Helen Lee Robertson; Doreen M Rabi; Ralf Paschke
Journal:  Thyroid Res       Date:  2021-02-25

Review 9.  Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management.

Authors:  Nik Krajnc; Gabriel Bsteh; Thomas Berger; Jan Mares; Hans-Peter Hartung
Journal:  Neurotherapeutics       Date:  2022-04-04       Impact factor: 6.088

10.  Thyroid nodules with macrocalcification: sonographic findings predictive of malignancy.

Authors:  Yun Joo Park; Jeong-Ah Kim; Eun Ju Son; Ji Hyun Youk; Eun-Kyung Kim; Jin Young Kwak; Cheong Soo Park
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.